Cargando…

Validation of the Parkinson's Disease Caregiver Burden Questionnaire in Progressive Supranuclear Palsy

Progressive supranuclear palsy (PSP) is an atypical Parkinson syndrome with axial akinetic-rigid symptoms, early postural instability, and ocular motor impairments. Patients experience a rapid loss of autonomy and care dependency; thus, caregivers must assist in the activities of daily living early...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klietz, Martin, Eichel, Hannah V., Staege, Selma, Kutschenko, Anna, Respondek, Gesine, Huber, Meret K., Greten, Stephan, Höglinger, Günter U., Wegner, Florian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8128535/ https://www.ncbi.nlm.nih.gov/pubmed/34046156 http://dx.doi.org/10.1155/2021/9990679

Ejemplares similares

One Year Trajectory of Caregiver Burden in Parkinson’s Disease and Analysis of Gender-Specific Aspects
por: Klietz, Martin, et al.
Publicado: (2021)

Relationship Satisfaction in People with Parkinson’s Disease and Their Caregivers: A Cross-Sectional Observational Study
por: Heine, Johanne, et al.
Publicado: (2021)

Reduction in Volume of Nucleus Basalis of Meynert Is Specific to Parkinson’s Disease and Progressive Supranuclear Palsy but Not to Multiple System Atrophy
por: Rogozinski, Sophia, et al.
Publicado: (2022)

Alexithymia Is Associated with Reduced Quality of Life and Increased Caregiver Burden in Parkinson’s Disease
por: Klietz, Martin, et al.
Publicado: (2020)

DescribePSP and ProPSP: German Multicenter Networks for Standardized Prospective Collection of Clinical Data, Imaging Data, and Biomaterials of Patients With Progressive Supranuclear Palsy
por: Respondek, Gesine, et al.
Publicado: (2021)

An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability
por: Kurz, Carolin, et al.
Publicado: (2016)

Mindfulness and Psychological Flexibility are Inversely Associated with Caregiver Burden in Parkinson’s Disease
por: Klietz, Martin, et al.
Publicado: (2020)

Validation of mobile eye-tracking as novel and efficient means for differentiating progressive supranuclear palsy from Parkinson's disease
por: Marx, Svenja, et al.
Publicado: (2012)

The Lived Experiences of People with Progressive Supranuclear Palsy and Their Caregivers
por: Respondek, Gesine, et al.
Publicado: (2022)

Neuropsychiatric Symptoms in Parkinson’s Disease Patients Are Associated with Reduced Health-Related Quality of Life and Increased Caregiver Burden
por: von Eichel, Hannah, et al.
Publicado: (2022)

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017
por: Zella, Maria Angela Samis, et al.
Publicado: (2020)

Does the Anti‐Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? No
por: Höglinger, Günter U.
Publicado: (2021)

Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
por: Grimm, Max-Joseph, et al.
Publicado: (2020)

Distribution patterns of tau pathology in progressive supranuclear palsy
por: Kovacs, Gabor G., et al.
Publicado: (2020)

Inferring the sequence of brain volume changes in progressive supranuclear palsy using MRI
por: Franzmeier, Nicolai, et al.
Publicado: (2022)

Potential of Non-Coding RNA as Biomarkers for Progressive Supranuclear Palsy
por: Simoes, Fabio A., et al.
Publicado: (2022)

Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson’s Disease?
por: Krey, Lea, et al.
Publicado: (2021)

Patient Safety in a Box: Implementation and Evaluation of the Emergency Box in Geriatric and Parkinson Patients
por: Krey, Lea, et al.
Publicado: (2021)

Analysis of Parkinson’s Disease Outpatient Counselling for Advance Directive Creation: A Cross-Sectional Questionnaire-Based Survey of German General Practitioners and Neurologists
por: Jensen, Ida, et al.
Publicado: (2022)

Variation at the TRIM11 locus modifies progressive supranuclear palsy phenotype
por: Jabbari, Edwin, et al.
Publicado: (2018)

Association of Motor and Cognitive Symptoms with Health-Related Quality of Life and Caregiver Burden in a German Cohort of Advanced Parkinson's Disease Patients
por: Klietz, M., et al.
Publicado: (2020)

Caregiver burden and health-related quality of life in idiopathic dystonia patients under botulinum toxin treatment: a cross-sectional study
por: Drexel, S. C., et al.
Publicado: (2019)

Caregiver strain in progressive supranuclear palsy and corticobasal syndromes
por: Kellermair, Lukas, et al.
Publicado: (2021)

Clinical Features Observed in General Practice Associated With the Subsequent Diagnosis of Progressive Supranuclear Palsy
por: Kwasny, Mary J., et al.
Publicado: (2021)

Analysis of Transition of Patients with Parkinson’s Disease into Institutional Care: A Retrospective Pilot Study
por: Jensen, Ida, et al.
Publicado: (2021)

Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for in vitro Assessment of Progressive Supranuclear Palsy Tau Pathology With [(18)F]PI-2620
por: Willroider, Marie, et al.
Publicado: (2021)

Assessment of (18)F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy
por: Brendel, Matthias, et al.
Publicado: (2020)

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database
por: Viscidi, Emma, et al.
Publicado: (2021)

Reduced Expression of GABA(A) Receptor Alpha2 Subunit Is Associated With Disinhibition of DYT-THAP1 Dystonia Patient-Derived Striatal Medium Spiny Neurons
por: Staege, Selma, et al.
Publicado: (2021)

Case report: Early-onset Parkinson's disease with initial spastic paraparesis and hyperreflexia caused by compound heterozygous PRKN-gene exon 2 and 4 deletions
por: Jensen, Ida, et al.
Publicado: (2022)

The Burden of Progressive Supranuclear Palsy on Patients, Caregivers, and Healthcare Systems by PSP Phenotype: A Cross-Sectional Study
por: Pillas, Demetris, et al.
Publicado: (2022)

Parkinson disease and progressive supranuclear palsy: protein expression in skin
por: Rodríguez‐Leyva, Ildefonso, et al.
Publicado: (2016)

Sensitivity and Specificity of the ECAS in Parkinson's Disease and Progressive Supranuclear Palsy
por: Foley, Jennifer A., et al.
Publicado: (2018)

Drug safety profiles in geriatric patients with Parkinson’s disease using the FORTA (Fit fOR The Aged) classification: results from a mono-centric retrospective analysis
por: Greten, S., et al.
Publicado: (2020)

Longitudinal changes of early motor and cognitive symptoms in progressive supranuclear palsy: the OxQUIP study
por: Pereira, Marta F, et al.
Publicado: (2022)

Tau burden and the functional connectome in Alzheimer’s disease and progressive supranuclear palsy
por: Cope, Thomas E, et al.
Publicado: (2018)

Consensus-Based Recommendations for Advance Directives of People with Parkinson’s Disease in Regard to Typical Complications by German Movement Disorder Specialists
por: Klietz, Martin, et al.
Publicado: (2020)

Cerebral magnetic resonance elastography in supranuclear palsy and idiopathic Parkinson's disease()
por: Lipp, Axel, et al.
Publicado: (2013)

Widespread diffusion changes differentiate Parkinson's disease and progressive supranuclear palsy
por: Talai, Aron S., et al.
Publicado: (2018)

Early Impairment of Chopsticks Skills in Parkinsonism Suggests Progressive Supranuclear Palsy
por: Kim, Young Eun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8nqj293koka7qa50chb55u5pua